UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044273
Receipt number R000050566
Scientific Title The effects of gargling or consuming tea on preventive effect of influenza infections and acute upper respiratory tract infections -A systematic review and meta-analysis.
Date of disclosure of the study information 2021/05/20
Last modified on 2021/11/18 09:24:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of gargling or consuming tea on preventive effect of influenza infections and acute upper respiratory tract infections
-A systematic review and meta-analysis.

Acronym

The effects of gargling or consuming tea on preventive effect of influenza infections and acute upper respiratory tract infections

Scientific Title

The effects of gargling or consuming tea on preventive effect of influenza infections and acute upper respiratory tract infections
-A systematic review and meta-analysis.

Scientific Title:Acronym

The effects of gargling or consuming tea on preventive effect of influenza infections and acute upper respiratory tract infections

Region

Japan


Condition

Condition

Influenza infections/acute upper respiratory infections

Classification by specialty

Infectious disease Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of continuous intake of tea on on influenza infections and acute upper respiratory tract infection.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of influenza and acute upper respiratory tract infections

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Randomized controlled trial
2) Prospective cohort study

Key exclusion criteria

1) Observational study and case
2) Systematic review and meta-analysis.
3) Not study in human.

Target sample size



Research contact person

Name of lead principal investigator

1st name Masanobu
Middle name
Last name Hibi

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

131-8501

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-356-30-7260

Email

hibi.masanobu@kao.com


Public contact

Name of contact person

1st name Mai
Middle name
Last name Umeda

Organization

Kao Corporation

Division name

Biological Science Research

Zip code

131-8501

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

TEL

+81-356-30-7260

Homepage URL


Email

umeda.mai@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Not applicable

Address

Not applicable

Tel

Not applicable

Email

Not applicable


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 13 Day

Date of IRB

2021 Year 05 Month 13 Day

Anticipated trial start date

2021 Year 05 Month 20 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To examine the effect of continuous intake of tea on on influenza infections and acute upper respiratory tract infection.


Management information

Registered date

2021 Year 05 Month 20 Day

Last modified on

2021 Year 11 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050566


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name